ITIH3 and gastric cancer: According to ROC, ITIH3 has a maximum sensitivity of 96% and a maximum specificity of 66% in the identification of gastric cancer. Furthermore, patients with early gastric cancer had considerably greater plasma levels of ITIH3 than non-cancerous patients (p < 0.001)